Literature DB >> 18265930

Relationship between antinuclear antibody and microalbuminuria in the general population: the Takahata study.

Mizue Ishikawa1, Tsuneo Konta, Zhimei Hao, Satoshi Takasaki, Hiroshi Abiko, Toshiyuki Takahashi, Ami Ikeda, Kazunobu Ichikawa, Yoko Shibata, Yasuchika Takeishi, Takeo Kato, Sumio Kawata, Isao Kubota.   

Abstract

BACKGROUND: Microalbuminuria, a marker of vascular damage, is associated with increased risk of progressive renal deterioration, cardiovascular disease and mortality. However, the relationship between antinuclear antibody (ANA) and microalbuminuria in the general population is unknown. Thus, we conducted a cross-sectional study to examine the relationship between ANA and microalbuminuria.
METHODS: The subjects of this community-based study were individuals over 40 years old in Takahata, Japan. The urine albumin-creatinine ratio (UACR) was calculated from a single-spot urine specimen collected in the morning. ANA was examined by enzyme immunoassay (EIA).
RESULTS: Among the 2,875 subjects (mean age 63 years; men 1,276; women 1,599), positive ANA (ANA index >or=20.0) was detected in 16.9% of the total population (men 12.9%, women 20.3%) and the prevalence of positive ANA increased with age. The prevalence of microalbuminuria (UACR 30-300 mg/g), but not macroalbuminuria (UACR > 300 mg/g), was significantly higher in the positive ANA group than the negative ANA group (24.1% vs. 16.0%, respectively, P < 0.001). Along with the increase of the ANA index, the prevalence of microalbuminuria and UACR levels were increased. Multivariate logistic regression analyses showed that ANA was significantly associated with microalbuminuria (odds ratio [OR] 1.63 and 95% confidence interval [95%CI] 1.27-2.10). These associations were significant in women, but not men, when examined separately.
CONCLUSIONS: These results indicate that the presence of ANA is associated with microalbuminuria in the general population, especially women.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18265930     DOI: 10.1007/s10157-008-0030-0

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  22 in total

1.  Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation.

Authors:  W F Keane; G Eknoyan
Journal:  Am J Kidney Dis       Date:  1999-05       Impact factor: 8.860

2.  Upregulation of adhesion molecule expression on endothelial cells by anti-DNA autoantibodies in systemic lupus erythematosus.

Authors:  K N Lai; J C Leung; K B Lai; K C Wong; C K Lai
Journal:  Clin Immunol Immunopathol       Date:  1996-12

Review 3.  Hypothesis: the aging paradox and autoimmune disease.

Authors:  E Talor; N R Rose
Journal:  Autoimmunity       Date:  1991       Impact factor: 2.815

4.  Antinuclear antibodies in healthy aging people: a prospective study.

Authors:  R M Xavier; Y Yamauchi; M Nakamura; Y Tanigawa; H Ishikura; T Tsunematsu; S Kobayashi
Journal:  Mech Ageing Dev       Date:  1995-03-01       Impact factor: 5.432

5.  Spontaneous development of organ-specific autoimmune lesions in aged C57BL/6 mice.

Authors:  Y Hayashi; M Utsuyama; C Kurashima; K Hirokawa
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

6.  Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study.

Authors:  T Konta; Z Hao; H Abiko; M Ishikawa; T Takahashi; A Ikeda; K Ichikawa; S Takasaki; I Kubota
Journal:  Kidney Int       Date:  2006-08       Impact factor: 10.612

7.  Association of autoantibodies with smoking, cardiovascular morbidity, and death in the Busselton population.

Authors:  J D Mathews; S Whittingham; B M Hooper; I R Mackay; N S Stenhouse
Journal:  Lancet       Date:  1973-10-06       Impact factor: 79.321

Review 8.  What is the evidence that microalbuminuria is a predictor of cardiovascular disease events?

Authors:  Matthew F Yuyun; Amanda I Adler; Nicholas J Wareham
Journal:  Curr Opin Nephrol Hypertens       Date:  2005-05       Impact factor: 2.894

9.  Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity.

Authors:  H L Hillege; W M Janssen; A A Bak; G F Diercks; D E Grobbee; H J Crijns; W H Van Gilst; D De Zeeuw; P E De Jong
Journal:  J Intern Med       Date:  2001-06       Impact factor: 8.989

10.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

View more
  6 in total

1.  Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women.

Authors:  Christine G Parks; Frederick W Miller; Minoru Satoh; Edward K L Chan; Zhanna Andrushchenko; Linda S Birnbaum; Todd A Jusko; Grace E Kissling; Mehul D Patel; Kathryn M Rose; Clarice Weinberg; Darryl C Zeldin; Dale P Sandler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-01       Impact factor: 4.254

2.  Relationships between values of antibodies to several connective tissue disease autoantigens and pulmonary function in a Japanese general population: the Takahata study.

Authors:  Hiroshi Nakano; Yoko Shibata; Sumito Inoue; Akira Igarashi; Keiko Yamauchi; Shuichi Abe; Masamichi Sato; Yasuko Aida; Keiko Nunomiya; Tomomi Kimura; Takako Nemoto; Tetsu Watanabe; Tsuneo Konta; Yoshiyuki Ueno; Takeo Kato; Takamasa Kayama; Isao Kubota
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

3.  The prevalence of antinuclear antibodies in the general population of china: a cross-sectional study.

Authors:  Ya-Ping Guo; Chun-Guang Wang; Xin Liu; Yi-Qian Huang; De-Li Guo; Xing-Zhuo Jing; Chun-Gang Yuan; Song Yang; Jin-Mei Liu; Meng-Si Han; Hong-Xing Li
Journal:  Curr Ther Res Clin Exp       Date:  2014-11-26

4.  Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study.

Authors:  Manas K Akmatov; Nadja Röber; Wolfgang Ahrens; Dieter Flesch-Janys; Julia Fricke; Halina Greiser; Kathrin Günther; Rudolf Kaaks; Yvonne Kemmling; Bastian Krone; Jakob Linseisen; Christa Meisinger; Susanne Moebus; Nadia Obi; Carlos A Guzman; Karsten Conrad; Frank Pessler
Journal:  Arthritis Res Ther       Date:  2017-06-06       Impact factor: 5.156

Review 5.  Antinuclear antibodies in autoimmune and allergic diseases.

Authors:  Bogna Grygiel-Górniak; Natalia Rogacka; Michał Rogacki; Mariusz Puszczewicz
Journal:  Reumatologia       Date:  2017-12-30

6.  Antinuclear antibodies and mortality in the National Health and Nutrition Examination Survey (1999-2004).

Authors:  Gregg E Dinse; Christine G Parks; Clarice R Weinberg; Helen C S Meier; Caroll A Co; Edward K L Chan; Frederick W Miller
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.